Identification and characterization of Huntington related pathology: An in vivo DKI imaging study

NeuroImage

Volumn 63, Issue 2, 2012, Pages 653-662

  Blockx, Ines ^a   Verhoye, Marleen ^a   Van Audekerke, Johan ^a   Bergwerf, Irene ^a   Kane, Jack X ^c   Delgado y Palacios, Rafael ^a   Veraart, Jelle ^a   Jeurissen, Ben ^a   Raber, Kerstin ^b   von Hörsten, Stephan ^b   Ponsaerts, Peter ^a   Sijbers, Jan ^a   Leergaard, Trygve B ^c   Van der Linden, Annemie ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Diffusion tensor imaging; Diffusional kurtosis imaging; Glia; Huntington disease; Neuroimaging; Transgenic rat model

Indexed keywords

ANATOMICAL VARIATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DIFFUSIONAL KURTOSIS IMAGING; FRONTAL CORTEX; GRAY MATTER; HUNTINGTON CHOREA; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; IN VIVO STUDY; MALE; MICROGLIA; NONHUMAN; OLIGODENDROGLIA; PATHOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY; WHITE MATTER;

ANIMALS; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; HUNTINGTON DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, TRANSGENIC;

EID: 84865486143     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.06.032     Document Type: Article

References (62)

1. Alexander A.L., Lee J.E., Lazar M., Field A.S. Diffusion tensor imaging of the brain. Neurotherapeutics 2007, 4:316-329.
2. Antonsen, B.A., Jiang, Y., Veraart, J., van Dongen, Y.C., Qu, H., Urbach, Y.K., Raber, K., Nguyen, H.P., Sijbers, J., von Hörsten, S., Ohnson, G.A., Leergaard, T.B., in press. Altered ex vivo diffusion MRI in basal ganglia of transgenic Huntington's disease rats. Brain Struct. Funct.
3. Ashburner J., Neelin P., Collins D.L., Evans A., Friston K. Incorporating prior knowledge into image registration. Neuroimage 1997, 6:344-352.
4. Aylward E.H., Sparks B.F., Field K.M., Yallapragada V., Shpritz B.D., Rosenblatt A., Brandt J., Gourley L.M., Liang K., Zhou H., Margolis R.L., Ross C.A. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 2004, 63:66-72.
5. Bartzokis G., Lu P.H., Tishler T.A., Fong S.M., Oluwadara B., Finn J.P., Huang D., Bordelon Y., Mintz J., Perlman S. Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem. Res. 2007, 32:1655-1664.
6. Basser P.J., Jones D.K. Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed. 2002, 15:456-467.
7. Basser P.J., Pajevic S. Statistical artifacts in diffusion tensor MRI (DT-MRI) caused by background noise. Magn. Reson. Med. 2000, 44:41-50.
8. Basser P.J., Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J. Magn. Reson. B 1996, 111:209-219.
9. Blockx I., De Groof G., Verhoye M., Van Audekerke J., Raber K., Poot D., Sijbers J., Osmand A.P., Von Horsten S., Van der Linden A. Microstructural changes observed with DKI in a transgenic Huntington rat model: Evidence for abnormal neurodevelopment. Neuroimage 2011, 59:957-967.
10. Blockx I., Van Camp N., Verhoye M., Boisgard R., Dubois A., Jego B., Jonckers E., Raber K., Siquier K., Kuhnast B., Dolle F., Nguyen H.P., Von Horsten S., Tavitian B., Van der Linden A. Genotype specific age related changes in a transgenic rat model of Huntington's disease. Neuroimage 2011, 58:1006-1016.
11. Bode F.J., Stephan M., Suhling H., Pabst R., Straub R.H., Raber K.A., Bonin M., Nguyen H.P., Riess O., Bauer A., Sjoberg C., Petersen A., von Horsten S. Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. Hum. Mol. Genet. 2008, 17:2595-2609.
12. Bohanna I., Georgiou-Karistianis N., Hannan A.J., Egan G.F. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Res. Rev. 2008, 58:209-225.
13. Buchel C., Wise R.J., Mummery C.J., Poline J.B., Friston K.J. Nonlinear regression in parametric activation studies. Neuroimage 1996, 4:60-66.
14. Cao C., Temel Y., Blokland A., Ozen H., Steinbusch H.W., Vlamings R., Nguyen H.P., von Horsten S., Schmitz C., Visser-Vandewalle V. Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel. Behav. Brain Res. 2006, 170:257-261.
15. Cepeda C., Wu N., Andre V.M., Cummings D.M., Levine M.S. The corticostriatal pathway in Huntington's disease. Prog. Neurobiol. 2007, 81:253-271.
16. Cheung M.M., Hui E.S., Chan K.C., Helpern J.A., Qi L., Wu E.X. Does diffusion kurtosis imaging lead to better neural tissue characterization? A rodent brain maturation study. Neuroimage 2009, 45:386-392.
17. Ciarmiello A., Cannella M., Lastoria S., Simonelli M., Frati L., Rubinsztein D.C., Squitieri F. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J. Nucl. Med. 2006, 47:215-222.
18. Cohen Y., Assaf Y. High b-value q-space analyzed diffusion-weighted MRS and MRI in neuronal tissues - a technical review. NMR Biomed. 2002, 15:516-542.
19. Delgado y Palacios R., Campo A., Henningsen K., Verhoye M., Poot D., Dijkstra J., Van A.J., Benveniste H., Sijbers J., Wiborg O., Van der Linden A. Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model. Biol. Psychiatry 2011, 70:449-457.
20. Douaud G., Behrens T.E., Poupon C., Cointepas Y., Jbabdi S., Gaura V., Golestani N., Krystkowiak P., Verny C., Damier P., Bachoud-Levi A.C., Hantraye P., Remy P. In vivo evidence for the selective subcortical degeneration in Huntington's disease. Neuroimage 2009, 46:958-966.
21. Duff K., Paulsen J.S., Beglinger L.J., Langbehn D.R., Stout J.C. Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol. Psychiatry 2007, 62:1341-1346.
22. Esmaeilzadeh M., Ciarmiello A., Squitieri F. Seeking brain biomarkers for preventive therapy in Huntington disease. CNS Neurosci. Ther. 2011, 17:368-386.
23. Gomez-Tortosa E., MacDonald M.E., Friend J.C., Taylor S.A., Weiler L.J., Cupples L.A., Srinidhi J., Gusella J.F., Bird E.D., Vonsattel J.P., Myers R.H. Quantitative neuropathological changes in presymptomatic Huntington's disease. Ann. Neurol. 2001, 49:29-34.
24. Gundersen H.J., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N., Moller A., Nielsen K., Nyengaard J.R., Pakkenberg B. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988, 96:857-881.
25. Gupta R.K., Hasan K.M., Trivedi R., Pradhan M., Das V., Parikh N.A., Narayana P.A. Diffusion tensor imaging of the developing human cerebrum. J. Neurosci. Res. 2005, 81:172-178.
26. Gupta R.K., Hasan K.M., Mishra A.M., Jha D., Husein M., Prasad K.N., Narayana P.A. High fractional anisotropy in brain abscesses versus other cystic intracranial lesions. AJNR Am. J. Neuroradiol. 2005, 26:1107-1114.
27. Hui E.S., Cheung M.M., Qi L., Wu E.X. Towards better MR characterization of neural tissues using directional diffusion kurtosis analysis. Neuroimage 2008, 42:122-134.
28. Jensen J.H., Helpern J.A., Ramani A., Lu H., Kaczynski K. Diffusional kurtosis imaging: the quantification of non-Gaussian water diffusion by means of magnetic resonance imaging. Magn. Reson. Med. 2005, 53:1432-1440.
29. Jensen J.H., Helpern J.A. MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed. 2010, 23:698-710.
30. Jones D.K., Horsfield M.A., Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn. Reson. Med. 1999, 42:515-525.
31. Kantor O., Temel Y., Holzmann C., Raber K., Nguyen H.P., Cao C., Turkoglu H.O., Rutten B.P., Visser-Vandewalle V., Steinbusch H.W., Blokland A., Korr H., Riess O., von Horsten S., Schmitz C. Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats. Neurobiol. Dis. 2006, 22:538-547.
32. Kloppel S., Draganski B., Golding C.V., Chu C., Nagy Z., Cook P.A., Hicks S.L., Kennard C., Alexander D.C., Parker G.J., Tabrizi S.J., Frackowiak R.S. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain 2008, 131:196-204.
33. Kloppel S., Draganski B., Golding C.V., Chu C., Nagy Z., Cook P.A., Hicks S.L., Kennard C., Alexander D.C., Parker G.J., Tabrizi S.J., Frackowiak R.S. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain 2008, 131:196-204.
34. Lu H., Jensen J.H., Ramani A., Helpern J.A. Three-dimensional characterization of non-gaussian water diffusion in humans using diffusion kurtosis imaging. NMR Biomed. 2006, 19:236-247.
35. Mascalchi M., Lolli F., Della N.R., Tessa C., Petralli R., Gavazzi C., Politi L.S., Macucci M., Filippi M., Piacentini S. Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 2004, 232:867-873.
36. Myers R.H., Vonsattel J.P., Paskevich P.A., Kiely D.K., Stevens T.J., Cupples L.A., Richardson E.P., Bird E.D. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J. Neuropathol. Exp. Neurol. 1991, 50:729-742.
37. Nath K., Husain M., Trivedi R., Kumar R., Prasad K.N., Rathore R.K., Gupta R.K. Clinical implications of increased fractional anisotropy in meningitis associated with brain abscess. J. Comput. Assist. Tomogr. 2007, 31:888-893.
38. Nguyen H.P., Kobbe P., Rahne H., Worpel T., Jager B., Stephan M., Pabst R., Holzmann C., Riess O., Korr H., Kantor O., Petrasch-Parwez E., Wetzel R., Osmand A., von Horsten S. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum. Mol. Genet. 2006, 15:3177-3194.
39. Paulsen J.S., Zimbelman J.L., Hinton S.C., Langbehn D.R., Leveroni C.L., Benjamin M.L., Reynolds N.C., Rao S.M. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. AJNR Am. J. Neuroradiol. 2004, 25:1715-1721.
40. Paulsen J.S., Magnotta V.A., Mikos A.E., Paulson H.L., Penziner E., Andreasen N.C., Nopoulos P.C. Brain structure in preclinical Huntington's disease. Biol. Psychiatry 2006, 59:57-63.
41. Paxinos G.a.W.C. The Rat Brain in Stereotaxic Coordinates 2006, Elsevier Academic Press, San Diego. sixth edition.
42. Petrasch-Parwez E., Nguyen H.P., Lobbecke-Schumacher M., Habbes H.W., Wieczorek S., Riess O., Andres K.H., Dermietzel R., von Horsten S. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease. J. Comp. Neurol. 2007, 501:716-730.
43. Reading S.A., Yassa M.A., Bakker A., Dziorny A.C., Gourley L.M., Yallapragada V., Rosenblatt A., Margolis R.L., Aylward E.H., Brandt J., Mori S., Van Z.P., Bassett S.S., Ross C.A. Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study. Psychiatry Res. 2005, 140:55-62.
44. Rosas H.D., Koroshetz W.J., Chen Y.I., Skeuse C., Vangel M., Cudkowicz M.E., Caplan K., Marek K., Seidman L.J., Makris N., Jenkins B.G., Goldstein J.M. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 2003, 60:1615-1620.
45. Rosas H.D., Feigin A.S., Hersch S.M. Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease. NeuroRx 2004, 1:263-272.
46. Rosas H.D., Tuch D.S., Hevelone N.D., Zaleta A.K., Vangel M., Hersch S.M., Salat D.H. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. Mov. Disord. 2006, 21:1317-1325.
47. Rosas H.D., Lee S.Y., Bender A.C., Zaleta A.K., Vangel M., Yu P., Fischl B., Pappu V., Onorato C., Cha J.H., Salat D.H., Hersch S.M. Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection". Neuroimage 2010, 49:2995-3004.
48. Sapp E., Kegel K.B., Aronin N., Hashikawa T., Uchiyama Y., Tohyama K., Bhide P.G., Vonsattel J.P., DiFiglia M. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol. 2001, 60:161-172.
49. Seppi K., Schocke M.F., Mair K.J., Esterhammer R., Weirich-Schwaiger H., Utermann B., Egger K., Brenneis C., Granata R., Boesch S., Poewe W., Wenning G.K. Diffusion-weighted imaging in Huntington's disease. Mov. Disord. 2006, 21:1043-1047.
50. Shin J.Y., Fang Z.H., Yu Z.X., Wang C.E., Li S.H., Li X.J. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J. Cell Biol. 2005, 171:1001-1012.
51. Solomon A.C., Stout J.C., Johnson S.A., Langbehn D.R., Aylward E.H., Brandt J., Ross C.A., Beglinger L., Hayden M.R., Kieburtz K., Kayson E., Julian-Baros E., Duff K., Guttman M., Nance M., Oakes D., Shoulson I., Penziner E., Paulsen J.S. Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia 2007, 45:1767-1776.
52. Stoffers D., Sheldon S., Kuperman J.M., Goldstein J., Corey-Bloom J., Aron A.R. Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study. Neurology 2010, 74:1208-1216.
53. Streit W.J. Microglial senescence: does the brain's immune system have an expiration date?. Trends Neurosci. 2006, 29:506-510.
54. Trivedi R., Malik G.K., Gupta R.K., Gupta A., Nath K., Prasad K.N., Purwar A., Rathore D., Rathore R.K., Narayana P.A. Increased anisotropy in neonatal meningitis: An indicator of meningeal inflammation. Neuroradiol. 2007, 49:767-775.
55. Van Camp N., Blockx I., Camon L., de Vera N., Verhoye M., Veraart J., Van Hecke W., Martinez E., Soria G., Sijbers J., Planas A.M., Van der Linden A. A complementary diffusion tensor imaging (DTI)-histological study in a model of Huntington's disease. Neurobiol. Aging 2012, 33:945-959. (Epub 2010 Aug 17).
56. Veraart J., Poot D.H., Van Hecke W., Blockx I., Van der Linden A., Verhoye M., Sijbers J. More accurate estimation of diffusion tensor parameters using diffusion Kurtosis imaging. Magn. Reson. Med. 2011, 65:138-145.
57. von Horsten S., Schmitt I., Nguyen H.P., Holzmann C., Schmidt T., Walther T., Bader M., Pabst R., Kobbe P., Krotova J., Stiller D., Kask A., Vaarmann A., Rathke-Hartlieb S., Schulz J.B., Grasshoff U., Bauer I., Vieira-Saecker A.M., Paul M., Jones L., Lindenberg K.S., Landwehrmeyer B., Bauer A., Li X.J., Riess O. Transgenic rat model of Huntington's disease. Hum. Mol. Genet. 2003, 12:617-624.
58. Winkler C., Gil J.M., Araujo I.M., Riess O., Skripuletz T., von H.S., Petersen A. Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat. Brain Res. Bull. 2006, 69:306-310.
59. Wolf R.C., Vasic N., Schonfeldt-Lecuona C., Landwehrmeyer G.B., Ecker D. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 2007, 130:2845-2857.
60. Wolf R.C., Vasic N., Schonfeldt-Lecuona C., Ecker D., Landwehrmeyer G.B. Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum. Brain Mapp. 2009, 30:327-339.
61. Wu E.X., Cheung M.M. MR diffusion kurtosis imaging for neural tissue characterization. NMR Biomed. 2010, 23:836-848.
62. Zuccato C., Valenza M., Cattaneo E. Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol. Rev. 2010, 90:905-981.